当前位置: X-MOL 学术Eur. Respir. Rev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis
European Respiratory Review ( IF 7.5 ) Pub Date : 2021-04-29 , DOI: 10.1183/16000617.0321-2020
Rodrigo Torres-Castro 1, 2 , Elena Gimeno-Santos 1, 3 , Jordi Vilaró 4 , Marta Roqué-Figuls 5, 6 , Jorge Moisés 1, 7 , Luis Vasconcello-Castillo 2 , Tanya Orizaga 1 , Joan Albert Barberà 1, 7, 8 , Isabel Blanco 7, 8, 9
Affiliation  

Background

Pulmonary hypertension (PH) is a frequent complication in patients with COPD.

Objective

To determine if, in patients with COPD, the presence of PH decreases exercise tolerance.

Methods

We included studies that analysed exercise tolerance using a cardiopulmonary exercise test (CPET) in patients with COPD with PH (COPD-PH) and without PH (COPD-nonPH). Two independent reviewers analysed the studies, extracted the data and assessed the quality of the evidence.

Results

Of the 4915 articles initially identified, seven reported 257 patients with COPD-PH and 404 patients with COPD-nonPH. The COPD-PH group showed differences in peak oxygen consumption (V'O2peak), –3.09 mL·kg–1·min–1 (95% CI –4.74 to –1.43, p=0.0003); maximum workload (Wmax), –20.5 W (95% CI –34.4 to –6.5, p=0.004); and oxygen pulse (O2 pulse), –1.24 mL·beat–1 (95% CI –2.40 to –0.09, p=0.03), in comparison to the group with COPD-nonPH. If we excluded studies with lung transplant candidates, the sensitivity analyses showed even bigger differences: V'O2, –4.26 mL·min–1·kg–1 (95% CI –5.50 to –3.02 mL·kg–1·min–1, p<0.00001); Wmax, –26.6 W (95% CI –32.1 to –21.1 W, p<0.00001); and O2 pulse, –2.04 mL·beat–1 (95% CI –2.92 to –1.15 mL·beat–1, p<0.0001).

Conclusion

Exercise tolerance was significantly lower in patients with COPD-PH than in patients with COPD-nonPH, particularly in nontransplant candidates.



中文翻译:

肺动脉高压对 COPD 患者运动耐量的影响:一项预后系统评价和荟萃分析

背景

肺动脉高压 (PH) 是 COPD 患者的常见并发症。

客观的

以确定在 COPD 患者中,PH 的存在是否会降低运动耐量。

方法

我们纳入了使用心肺运动试验 (CPET) 分析 COPD 伴 PH (COPD-PH) 和无 PH (COPD-nonPH) 患者运动耐量的研究。两名独立审查员分析了研究,提取了数据并评估了证据的质量。

结果

在最初确定的 4915 篇文章中,有 7 篇报道了 257 名 COPD-PH 患者和 404 名 COPD-nonPH 患者。COPD-PH 组表现出峰值耗氧量 ( V ' O 2peak ) 的差异,–3.09 mL·kg –1 ·min –1(95% CI –4.74 至 –1.43,p=0.0003);最大工作负荷 (W max ),–20.5 W(95% CI –34.4 至 –6.5,p=0.004);与 COPD-nonPH 组相比,氧脉搏(O 2脉搏)–1.24 mL·beat –1(95% CI –2.40 至 –0.09,p=0.03)。如果我们排除肺移植候选者的研究,则敏感性分析显示出更大的差异:V ' O 2 , –4.26 mL·min –1·kg –1(95% CI –5.50 至 –3.02 mL·kg –1 ·min –1,p<0.00001);W最大值,–26.6 W(95% CI –32.1 至 –21.1 W,p<0.00001);O 2脉搏,–2.04 mL·beat –1(95% CI –2.92 至 –1.15 mL·beat –1,p<0.0001)。

结论

COPD-PH 患者的运动耐量显着低于 COPD-nonPH 患者,特别是在非移植候选人中。

更新日期:2021-04-29
down
wechat
bug